Scholarly Index
Kenshi Suzuki
Japanese Red Cross Medical Center; 12,620 total citations; 442 total publications; best world rank #143
Japanese Red Cross Medical Center
12,620Total citations
442Total publications
42H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 388 | JP 3 | 97.81 |
| Protein Degradation and Inhibitors | Lifetime | 434 | JP 9 | 96.75 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 479 | JP 47 | 95.02 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 143 | JP 2 | 98.05 |
| Peptidase Inhibition and Analysis | 2021-2025 | 223 | JP 5 | 95.18 |
| Protein Degradation and Inhibitors | 2021-2025 | 205 | JP 3 | 95.61 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 835 | JP 18 | 92.08 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 409 | JP 24 | 86.77 |
| Cancer Mechanisms and Therapy | 2021-2025 | 378 | JP 25 | 83.79 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 786 | JP 18 | 84.91 |